← Back to headlines
Dyne Therapeutics Completes Phase 1/2 ACHIEVE Trial Enrollment
Dyne Therapeutics (DYN) has announced the successful conclusion of patient enrollment for its Phase 1/2 ACHIEVE clinical trial, marking a significant milestone in its drug development.
11 Jun, 10:20 — 11 Jun, 10:20
Sources
Showing 1 of 1 sources
